Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzoic Acid, 3-(2-(((4s)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)methylamino)ethyl)-, Methyl Ester
2. Methyl 3-(2-(((4s)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)(methyl)amino)ethyl)benzoate
1. 1593673-23-4
2. Msp-2017
3. (-)-msp-2017
4. Ms)-msp-2017
5. S82a18y42p
6. Methyl (s)-3-(2-((4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)(methyl)amino)ethyl)benzoate
7. Benzoic Acid, 3-(2-(((4s)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)methylamino)ethyl)- , Methyl Ester
8. Etripamil [usan:inn]
9. Unii-s82a18y42p
10. Etripamil [inn]
11. Etripamil (usan/inn)
12. Etripamil [usan]
13. Etripamil [who-dd]
14. Chembl3707312
15. Ex-a5306
16. Db12605
17. Hy-17611
18. Cs-0014689
19. D10932
20. Q27289030
21. Benzoic Acid, 3-(2-(((4s)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)methylamino)ethyl)-, Methyl Ester
22. Methyl 3-[2-[[(4s)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-methylamino]ethyl]benzoate
| Molecular Weight | 452.6 g/mol |
|---|---|
| Molecular Formula | C27H36N2O4 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 13 |
| Exact Mass | 452.26750763 g/mol |
| Monoisotopic Mass | 452.26750763 g/mol |
| Topological Polar Surface Area | 71.8 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of supraventricular arrhythmias
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Etripamil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etripamil, including repackagers and relabelers. The FDA regulates Etripamil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etripamil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etripamil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etripamil supplier is an individual or a company that provides Etripamil active pharmaceutical ingredient (API) or Etripamil finished formulations upon request. The Etripamil suppliers may include Etripamil API manufacturers, exporters, distributors and traders.
click here to find a list of Etripamil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Etripamil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etripamil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etripamil GMP manufacturer or Etripamil GMP API supplier for your needs.
A Etripamil CoA (Certificate of Analysis) is a formal document that attests to Etripamil's compliance with Etripamil specifications and serves as a tool for batch-level quality control.
Etripamil CoA mostly includes findings from lab analyses of a specific batch. For each Etripamil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etripamil may be tested according to a variety of international standards, such as European Pharmacopoeia (Etripamil EP), Etripamil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etripamil USP).
LOOKING FOR A SUPPLIER?
